1. Inicio
  2. Publicaciones
  3. Placental growth factor testing in the management of late preterm preeclampsia without severe features: a multicenter, randomized, controlled trial.

Placental growth factor testing in the management of late preterm preeclampsia without severe features: a multicenter, randomized, controlled trial.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Peguero, Anna
  • Herraiz, Ignacio
  • Perales, Alfredo
  • Melchor, Inigo
  • Villalain, Cecilia
  • Martinez-Portilla, Raigam
  • Mazarico, Edurne
  • Meler, Eva
  • Hernandez, Sandra
  • Matas, Isabel
  • Del Rio, Maria
  • Galindo, Alberto
  • Figueras, Francesc

Abstract

In women with late preterm preeclampsia, the optimal time for delivery remains a controversial topic, because of the fine balance between the maternal benefits from early delivery and the risks for prematurity. It remains challenging to define prognostic markers to identify women at highest risk for complications, in which case a selective, planned delivery may reduce the adverse maternal and perinatal outcomes.

Datos de la publicación

ISSN/ISSNe:
0002-9378, 1097-6868

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY  MOSBY-ELSEVIER

Tipo:
Article
Páginas:
3081-30814
PubMed:
33823150
Factor de Impacto:
2,948 SCImago ℠
Cuartil:
Q1 SCImago ℠

Citas Recibidas en Web of Science: 9

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • biomarkers, blood pressure, infant, morbidity, newborn, prediction, preeclampsia, therapy

Campos de Estudio

Cita

Compartir